[EN] ISOINDOLINONE DERIVATIVES AS IRAK4 MODULATORS<br/>[FR] DÉRIVÉS D'ISOINDOLINONE UTILISÉS EN TANT QUE MODULATEURS D'IRAK4
申请人:HOFFMANN LA ROCHE
公开号:WO2018234342A1
公开(公告)日:2018-12-27
Compounds of Formula (0), and stereoisomers and pharmaceutically acceptable salts thereof, as well as methods of use as Interleukin-1 Receptor Associated Kinase (IRAK4) inhibitors are described herein.
本文描述了公式(0)的化合物,以及其立体异构体和药用可接受的盐,以及作为白细胞介素-1受体相关激酶(IRAK4)抑制剂的使用方法。